President Trump seeks final stamp on drug prices with sweeping rule

President Donald Trump has resurrected a long-delayed plan to slash drug prices, with advisers pitching him on an added benefit: It would hit an industry that Trump believes slow-walked coronavirus vaccine development until after the election. The about-face came after Oval Office meetings last week where Trump railed against vaccine maker Pfizer for not revealing that its vaccine was more than 90 percent effective until after Election Day, according to three people familiar with the discussion.